Nanomaterials for clinical applications : case studies in nanomedicines / edited by Natassa Pippa and Costas Demetzos.

Call Number
620/.5
Title
Nanomaterials for clinical applications : case studies in nanomedicines / edited by Natassa Pippa and Costas Demetzos.
Publication
Amsterdam : Elsevier, 2020.
Physical Description
1 online resource
Series
Micro and nano technologies
Notes
Includes index.
Contents
Front Cover -- Nanomaterials for Clinical Applications -- Copyright Page -- Contents -- List of contributors -- 1. Solid lipid nanoparticles in dermaceuticals -- 1.1 General introduction -- 1.2 Why solid lipid nanoparticles? -- 1.2.1 Formulation aspects -- 1.2.2 Physiological aspects -- 1.3 Evolution of lipidic nanoparticles from solid lipid nanoparticles to nanostructured lipid carriers -- 1.4 Cosmetic and topical applications of solid lipid nanoparticles -- 1.5 Skin penetration with solid lipid nanoparticles -- 1.6 Mechanism of drug penetration with solid lipid nanoparticles
1.7 Incorporation into semisolid vehicle -- 1.8 Case studies of successful topical delivery with lipidic nanoparticles -- 1.8.1 Delivery of antimicrobials -- 1.9 Delivery of agents for other skin diseases -- 1.9.1 Solid lipid nanoparticles for cosmetic applications -- 1.10 Conclusions -- References -- 2. Cyclodextrin-based drug delivery systems -- 2.1 Cyclodextrins-structure, physiochemical properties, and toxicological profile -- 2.2 Cyclodextrin inclusion complexes-formation, stability, and application in drug delivery -- 2.3 Cyclodextrin-based products in clinical practice
2.3.3.1 Cyclodextrins in control of obesity and hyperlipidemia -- References -- 3. Lipid vesicles for (trans)dermal administration -- 3.1 (Trans)dermal drug-delivery systems -- 3.1.1 Human skin barrier to xenobiotics -- 3.2 Lipid vesicles for breaching the skin barrier -- 3.2.1 Conventional liposomes -- 3.2.2 Transfersomes -- 3.2.3 Ethanol-based lipid vesicles -- 3.2.3.1 Ethosomes -- 3.2.3.2 Transethosomes -- 3.2.3.3 Other lipid vesicles -- 3.3 Liposomal formulation in clinics -- 3.3.1 Conventional liposomes -- 3.3.2 Transfersomes -- 3.3.3 Ethosomes -- 3.4 Final remarks -- References
4. Stimuli-responsive nanocarriers for drug delivery -- 4.1 Introduction -- 4.2 Types of stimuli -- 4.2.1 pH-responsive nanosystems -- 4.2.2 Thermoresponsive nanosystems -- 4.3 Development of chimeric stimuli-responsive liposomes with incorporated stimuli-responsive polymers -- 4.3.1 pH-responsive liposomes -- 4.3.2 Thermoresponsive liposomes -- 4.4 Thermotropic behavior of stimuli-responsive liposomes -- 4.4.1 Thermal analysis on pH-responsive liposomes -- 4.4.2 Thermal analysis of thermoresponsive liposomes -- 4.5 Physicochemical properties of stimuli-responsive liposomes
Added Author
Pippa, Natassa.
Demetzos, Costas.
Subject
NANOPARTICLES.
Nanoparticles
Nanoparticules.
Nanoparticles.
Electronic books.
Electronic books.
Multimedia
Total Ratings: 0
No records found to display.
 
 
 
04169cam a2200541 a 4500
001
 
 
vtls001596342
003
 
 
VRT
005
 
 
20220902124800.0
006
 
 
m     o  d       
007
 
 
cr |n|||||||||
008
 
 
220902s2020    ne      o     001 0 eng d
015
$a GBC027244 $2 bnb
016
7
$a 019718644 $2 Uk
019
$a 1141511300
020
$a 9780128168769 $q (electronic bk.)
020
$a 0128168765 $q (electronic bk.)
020
$z 9780128167052
020
$z 012816705X
035
$a (OCoLC)1141223334 $z (OCoLC)1141511300
035
$a (OCoLC)on1141223334
039
9
$y 202209021248 $z santha
040
$a YDX $b eng $e pn $c YDX $d OPELS $d UKMGB $d UKAHL $d OCLCF $d EBLCP $d OCLCQ $d OCLCO $d K6U
050
4
$a RS201.N35
082
0
4
$a 620/.5 $2 23
245
0
0
$a Nanomaterials for clinical applications : $b case studies in nanomedicines / $c edited by Natassa Pippa and Costas Demetzos.
260
$a Amsterdam : $b Elsevier, $c 2020.
300
$a 1 online resource
336
$a text $b txt $2 rdacontent
337
$a computer $b c $2 rdamedia
338
$a online resource $b cr $2 rdacarrier
490
1
$a Micro and nano technologies
500
$a Includes index.
505
0
$a Front Cover -- Nanomaterials for Clinical Applications -- Copyright Page -- Contents -- List of contributors -- 1. Solid lipid nanoparticles in dermaceuticals -- 1.1 General introduction -- 1.2 Why solid lipid nanoparticles? -- 1.2.1 Formulation aspects -- 1.2.2 Physiological aspects -- 1.3 Evolution of lipidic nanoparticles from solid lipid nanoparticles to nanostructured lipid carriers -- 1.4 Cosmetic and topical applications of solid lipid nanoparticles -- 1.5 Skin penetration with solid lipid nanoparticles -- 1.6 Mechanism of drug penetration with solid lipid nanoparticles
505
8
$a 1.7 Incorporation into semisolid vehicle -- 1.8 Case studies of successful topical delivery with lipidic nanoparticles -- 1.8.1 Delivery of antimicrobials -- 1.9 Delivery of agents for other skin diseases -- 1.9.1 Solid lipid nanoparticles for cosmetic applications -- 1.10 Conclusions -- References -- 2. Cyclodextrin-based drug delivery systems -- 2.1 Cyclodextrins-structure, physiochemical properties, and toxicological profile -- 2.2 Cyclodextrin inclusion complexes-formation, stability, and application in drug delivery -- 2.3 Cyclodextrin-based products in clinical practice
505
8
$a 2.3.3.1 Cyclodextrins in control of obesity and hyperlipidemia -- References -- 3. Lipid vesicles for (trans)dermal administration -- 3.1 (Trans)dermal drug-delivery systems -- 3.1.1 Human skin barrier to xenobiotics -- 3.2 Lipid vesicles for breaching the skin barrier -- 3.2.1 Conventional liposomes -- 3.2.2 Transfersomes -- 3.2.3 Ethanol-based lipid vesicles -- 3.2.3.1 Ethosomes -- 3.2.3.2 Transethosomes -- 3.2.3.3 Other lipid vesicles -- 3.3 Liposomal formulation in clinics -- 3.3.1 Conventional liposomes -- 3.3.2 Transfersomes -- 3.3.3 Ethosomes -- 3.4 Final remarks -- References
505
8
$a 4. Stimuli-responsive nanocarriers for drug delivery -- 4.1 Introduction -- 4.2 Types of stimuli -- 4.2.1 pH-responsive nanosystems -- 4.2.2 Thermoresponsive nanosystems -- 4.3 Development of chimeric stimuli-responsive liposomes with incorporated stimuli-responsive polymers -- 4.3.1 pH-responsive liposomes -- 4.3.2 Thermoresponsive liposomes -- 4.4 Thermotropic behavior of stimuli-responsive liposomes -- 4.4.1 Thermal analysis on pH-responsive liposomes -- 4.4.2 Thermal analysis of thermoresponsive liposomes -- 4.5 Physicochemical properties of stimuli-responsive liposomes
650
0
$a NANOPARTICLES.
650
2
$a Nanoparticles $0 (DNLM)D053758
650
6
$a Nanoparticules. $0 (CaQQLa)201-0262530
650
7
$a Nanoparticles. $2 fast $0 (OCoLC)fst01032624
655
0
$a Electronic books.
655
4
$a Electronic books.
700
1
$a Pippa, Natassa.
700
1
$a Demetzos, Costas.
776
0
8
$i Print version: $t Nanomaterials for clinical applications. $d Amsterdam : Elsevier, 2020 $z 012816705X $z 9780128167052 $w (OCoLC)1109769616
830
0
$a Micro & nano technologies.
856
4
0
$3 ScienceDirect $u https://www.sciencedirect.com/science/book/9780128167052
999
$a VIRTUA               
No Reviews to Display
Notes
Includes index.
Contents
Front Cover -- Nanomaterials for Clinical Applications -- Copyright Page -- Contents -- List of contributors -- 1. Solid lipid nanoparticles in dermaceuticals -- 1.1 General introduction -- 1.2 Why solid lipid nanoparticles? -- 1.2.1 Formulation aspects -- 1.2.2 Physiological aspects -- 1.3 Evolution of lipidic nanoparticles from solid lipid nanoparticles to nanostructured lipid carriers -- 1.4 Cosmetic and topical applications of solid lipid nanoparticles -- 1.5 Skin penetration with solid lipid nanoparticles -- 1.6 Mechanism of drug penetration with solid lipid nanoparticles
1.7 Incorporation into semisolid vehicle -- 1.8 Case studies of successful topical delivery with lipidic nanoparticles -- 1.8.1 Delivery of antimicrobials -- 1.9 Delivery of agents for other skin diseases -- 1.9.1 Solid lipid nanoparticles for cosmetic applications -- 1.10 Conclusions -- References -- 2. Cyclodextrin-based drug delivery systems -- 2.1 Cyclodextrins-structure, physiochemical properties, and toxicological profile -- 2.2 Cyclodextrin inclusion complexes-formation, stability, and application in drug delivery -- 2.3 Cyclodextrin-based products in clinical practice
2.3.3.1 Cyclodextrins in control of obesity and hyperlipidemia -- References -- 3. Lipid vesicles for (trans)dermal administration -- 3.1 (Trans)dermal drug-delivery systems -- 3.1.1 Human skin barrier to xenobiotics -- 3.2 Lipid vesicles for breaching the skin barrier -- 3.2.1 Conventional liposomes -- 3.2.2 Transfersomes -- 3.2.3 Ethanol-based lipid vesicles -- 3.2.3.1 Ethosomes -- 3.2.3.2 Transethosomes -- 3.2.3.3 Other lipid vesicles -- 3.3 Liposomal formulation in clinics -- 3.3.1 Conventional liposomes -- 3.3.2 Transfersomes -- 3.3.3 Ethosomes -- 3.4 Final remarks -- References
4. Stimuli-responsive nanocarriers for drug delivery -- 4.1 Introduction -- 4.2 Types of stimuli -- 4.2.1 pH-responsive nanosystems -- 4.2.2 Thermoresponsive nanosystems -- 4.3 Development of chimeric stimuli-responsive liposomes with incorporated stimuli-responsive polymers -- 4.3.1 pH-responsive liposomes -- 4.3.2 Thermoresponsive liposomes -- 4.4 Thermotropic behavior of stimuli-responsive liposomes -- 4.4.1 Thermal analysis on pH-responsive liposomes -- 4.4.2 Thermal analysis of thermoresponsive liposomes -- 4.5 Physicochemical properties of stimuli-responsive liposomes
Subject
NANOPARTICLES.
Nanoparticles
Nanoparticules.
Nanoparticles.
Electronic books.
Electronic books.
Multimedia